27 results on '"Greenspan, S.L."'
Search Results
2. COVID-19 and effects on osteoporosis management: the patient perspective from a National Osteoporosis Foundation survey
3. Correction to: How has COVID-19 affected the treatment of osteoporosis? An IOF-NOF-ESCEO global survey
4. The Association of Bone Turnover Markers with Muscle Function, Falls, and Frailty in Older Women in Long-Term Care
5. Bisphosphonate drug holidays
6. Does Zoledronic Acid Improve Appendicular Lean Mass in Older Women with Osteoporosis? A Sub-Analysis of a Randomized Clinical Trial
7. The effect of risedronate on hip structural geometry in chemotherapy-induced postmenopausal women with or without use of aromatase inhibitors: A 2-year trial
8. Zoledronic acid and bone health in older adults with cognitive impairment
9. Effect of risedronate on hip structural geometry: A 1-year, double-blind trial in chemotherapy-induced postmenopausal women
10. Uncoupling of Bone Turnover Following Hip Replacement
11. Factors related to the use of bone densitometry: survey responses of 494 primary care physicians in New England
12. Clinical Performance of a Highly Portable, Scanning Calcaneal Ultrasonometer
13. Effects of Teriparatide Compared with Risedronate on the Risk of Fractures in Subgroups of Postmenopausal Women with Severe Osteoporosis: The VERO Trial
14. THU0490 Temporal increases in side effect concerns of osteoporosis medications among women with previous fractures
15. THU0472 Factors associated with readiness for adopting osteoporosis treatment change
16. Increase in Fracture Risk Following Unintentional Weight Loss in Postmenopausal Women: The Global Longitudinal Study of Osteoporosis in Women: Journal of Bone and Mineral Research
17. Odanacatib for the treatment of postmenopausal osteoporosis: development history and design and participant characteristics of LOFT, the Long-Term Odanacatib Fracture Trial (vol 26, pg 699, 2015)
18. DETECTING SARCOPENIA IN LONG-TERM CARE RESIDENTS
19. Effects of once-yearly zoledronic acid 5mg in combination with teriparatide (PTH) on postmenopausal women with osteoporosis
20. Failure to perceive increased risk of fracture in women aged 55 years and older. The global longitudinal study of osteoporosis in women
21. Gains in lumbar spine BMD in highly compliant patients treated with PTH (1–84)
22. Burden of non-hip–non-vertebral fractures in postmenopausal women 55 years and older. The global longitudinal study of osteoporosis in women
23. 91282304 Skeletal integrity in premenopausal and postmenopausal women receiving long-term L-thyroxine therapy
24. Effects of once-yearly zoledronic acid 5 mg in combination with teriparatide (PTH) on postmenopausal women with osteoporosis
25. Efficacy of fosamax versus evista comparison trial: results of a randomized, multicenter study
26. Forord
27. Effects of once-yearly zoledronic acid 5mg in combination with teriparatide (PTH) on postmenopausal women with osteoporosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.